X

Trial Profile

A Phase 3 Study of Ketamine in Alcohol Use Disorder in United States

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 30 Aug 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ketamine (Primary)
Indications Alcoholism
Focus Registrational; Therapeutic Use
Sponsors Awakn Life Sciences

Most Recent Events

30 Aug 2022 New trial record
14 Aug 2022 According to Awakn Life Sciences media release, company has applied for several grants, one of which the company expects to receive a response on by end of Q2, and if successful, would cover a substantial amount of the cost
14 Aug 2022 According to Awakn Life Sciences media release, company will receive regulatory and ethics approval in H2 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com